These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8217803)

  • 1. An alternative strategy for identification of type IIA VWD mutations.
    Winter PC; Mayne EE
    Br J Haematol; 1993 Jul; 84(3):521-3. PubMed ID: 8217803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB.
    Piétu G; Ribba AS; de Paillette L; Chérel G; Lavergne JM; Bahnak BR; Meyer D
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):415-21. PubMed ID: 1420817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease.
    Gaucher C; Mercier B; Jorieux S; Oufkir D; Mazurier C
    Br J Haematol; 1991 Aug; 78(4):506-14. PubMed ID: 1832934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX.
    Lavergne JM; De Paillette L; Bahnak BR; Ribba AS; Fressinaud E; Meyer D; Pietu G
    Br J Haematol; 1992 Sep; 82(1):66-72. PubMed ID: 1419804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr).
    Iannuzzi MC; Hidaka N; Boehnke M; Bruck ME; Hanna WT; Collins FS; Ginsburg D
    Am J Hum Genet; 1991 Apr; 48(4):757-63. PubMed ID: 1673047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method.
    Inbal A; Englender T; Kornbrot N; Randi AM; Castaman G; Mannucci PM; Sadler JE
    Blood; 1993 Aug; 82(3):830-6. PubMed ID: 8338947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three distinct candidate point mutations of the von Willebrand factor gene in four patients with type IIA von Willebrand disease.
    Sugiura I; Matsushita T; Tanimoto M; Takahashi I; Yamazaki T; Yamamoto K; Takamatsu J; Kamiya T; Saito H
    Thromb Haemost; 1992 Jun; 67(6):612-7. PubMed ID: 1380739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An HphI-polymorphism in exon 28 of the von Willebrand factor gene, and its frequency among patients with various forms of von Willebrand's disease.
    Donnér M; Holmberg L; Kristoffersson AC; Nilsson IM
    Br J Haematol; 1991 Jul; 78(3):403-7. PubMed ID: 1873222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A de novo mutation in exon 28 of the von Willebrand factor gene in a patient with type IIA von Willebrand's disease coincides with an MboI polymorphism in the von Willebrand factor pseudogene.
    Pérez-Casal M; Daly M; Peake I
    Hum Mol Genet; 1993 Dec; 2(12):2159-61. PubMed ID: 7906590
    [No Abstract]   [Full Text] [Related]  

  • 10. A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele.
    Peerlinck K; Eikenboom JC; Ploos Van Amstel HK; Sangtawesin W; Arnout J; Reitsma PH; Vermylen J; Briët E
    Br J Haematol; 1992 Mar; 80(3):358-63. PubMed ID: 1581215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.
    Verweij CL; Quadt R; Briët E; Dubbeldam K; van Ommen GB; Pannekoek H
    J Clin Invest; 1988 Apr; 81(4):1116-21. PubMed ID: 2895123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The von Willebrand factor gene and genetics of von Willebrand's disease.
    Ginsburg D
    Mayo Clin Proc; 1991 May; 66(5):506-15. PubMed ID: 2030619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor.
    Donnér M; Kristoffersson AC; Berntorp E; Scheibel E; Thorsen S; Dahlbäck B; Nilsson IM; Holmberg L
    Eur J Haematol; 1993 Jul; 51(1):38-44. PubMed ID: 8348943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid genotype analysis in type 2B von Willebrand's disease using a universal heteroduplex generator.
    Wood N; Standen GR; Murray EW; Lillicrap D; Holmberg L; Peake IR; Bidwell J
    Br J Haematol; 1995 Jan; 89(1):152-6. PubMed ID: 7833255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
    Ginsburg D; Konkle BA; Gill JC; Montgomery RR; Bockenstedt PL; Johnson TA; Yang AY
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3723-7. PubMed ID: 2786201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.
    Keeney S; Cumming A; Hay C
    Thromb Haemost; 1999 Nov; 82(5):1446-50. PubMed ID: 10595636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
    Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
    Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe type III von Willebrand's disease caused by deletion of exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individual.
    Peake IR; Liddell MB; Moodie P; Standen G; Mancuso DJ; Tuley EA; Westfield LA; Sorace JM; Sadler JE; Verweij CL
    Blood; 1990 Feb; 75(3):654-61. PubMed ID: 2297569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA.
    Eikenboom JC; Ploos van Amstel HK; Reitsma PH; Briët E
    Thromb Haemost; 1992 Oct; 68(4):448-54. PubMed ID: 1448779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.